Cartilage proteoglycans (PG) can induce and act as a target in autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis and relapsing polychondritis [ 1-71, Synovial fluids and cells from patients with rheumatoid arthritis contain large numbers of activated monocytes and macrophages which express class I1 antigens [8, 91 and are therefore capable of acting as antigen-presenting cells in immune reactions. Increased infiltration by these cells is often accompanied by large increases in lysosomal hydrolases and proteases in synovial fluids of both naturally occurring and experimental models of arthritis [ 101. Macrophages also secrete a number of cytokines, including interleukin 1 and tumour necrosis factor-a (TNF-a), both of which can promote dcstruction o f cartilage matrix and bone Ahhreviations used: PG. proteoplycan; PMSF, phenylmethylsulphonylfluoride.
[ 11 -13] . The presence of these cytokines in synovial fluid may stimulate macrophages or chondrocytes to secrete enzymes which can degrade cartilage matrix, therefore exposing epitopes which may initiate or prolong an antigendriven arthritis. Although endocytosis and degradation of PG has been described in human fibroblasts [ 141 and liver endothelial cells [ 15. 161. little is yet known about the processing of these molecules by macrophages and the effect of such processing on their antigenicity.
We investigated processing using human articular cartilage PG, a gift from M. Bayliss, Kennedy Institute [ 171. This was labelled using 2 mCi of Iz51/5 mg of PG [ 181 and free label was removed by gel filtration. Some samples o f iodinated PG aggregate were subjected to proteolysis using either trypsin (1.5 mg of PG: 3 pg of trypsin for 6 h at 37°C in 0.05 M-Tris, 0.1 M-NaCI buffer, pH 7.5) or stromelysin (1.5 mg of PG: 1 unit of stromelysin for 16 h at 37°C in 0.0 1 M-CaCI,, 0.05 MTris, 0.1 M-NaCI, pH 7.5). Trypsin activity was blocked with soya bean trypsin inhibitor and stromelysin activity was stopped by freezing samples at -20°C until digested fragments were separated from the proteinase by gel filtra- Fraction no. Fraction no. 634th MEETING, BATH tion o n Sepharose CL-6B (see Fig. 1 a) . Aliquots of iodinated PG and selected proteolytic fragments were incubated with the human monocytic cell line THP-1 [19] using 5 x lo4 c.p.m. and 3 x lo6 cells. The location of PG in the cells after uptake was determined after disruption by N, cavitation followed by subcellular fractionation on Percoll gradients ( 1 .05 g/ml starting density) [20] . Hexosaminidase and 5'-nucleotidase activities were used as markers for lysosomes and plasma membrane, respectively. The amount o f PG taken up by the THP-I cells continued t o increase with time for the first 45 min after which it reached a plateau representing 5"/0 of the initial total label. Pretreatment of the cells with the serine proteinase inhibitor phenylmethylsulphonylfluoride (PMSF ) or lowering the temperature to 4°C reduced uptake by 20% and 40%, respectively. Ninety percent of the PG taken up during 60 min of incubation was resistant to stripping in 0.1 M-sodium acetate, 0.15 M-NaCI buffer, pH 3.5, and was presumably therefore intracellular. After a further 60 min chase in fresh medium, SOo/" of this had been secreted back into the medium. Gel chromatography showed that this secreted PG had been extensively degraded, so that only 20% was excluded from Sepharose CL-6B compared with LOOYO of the original material. The remaining 80% contained a polydisperse range of fragments ranging in size from a few kDa to several hundred kDa. Subcellular fractionation of disrupted cells on Percoll after uptake for 60 min confirmed that 81% of the PG was contained within lysosomes, while only 19% was membrane associated.
Samples of PG that had been digested with trypsin or stromelysin were chromatographed on Sepharose CL-6B (Fig. 1) and selected fractions from each profile tested for uptake by THP-I cells. Cells were then stripped in acetate buffer, pH 3.5, to determine the percentage of this label that remained surface associated. Some fractions were taken up much more rapidly than others (Fig. 1) and a high proportion of these fragments were removed from the cells by the acid buffer in contrast to the results obtained with whole PG aggregate. In particular the rate of uptake of fraction 70 ( K , , = 0 . 7 7 ; Fig. 1 ) was very rapid, a plateau of surfacebound material being achieved within 2-4 min incubation. When THP-I cells were pulsed for 5 min with fraction 70 and then chased in fresh medium, the amount of cellassociated label declined to about 15% of the initial value within 30 min. The remaining surface-associated label, however. was stable over a period of 2 h and remained susceptible to stripping at low pH. Uptake of these fragments was reduced greatly to only 20"h of normal levels at 4°C or in the presence of PMSF. When whole PG aggregate and proteolytic PG fragments were offered to resident mouse peritoneal macrophages, which do not usually express class II antigens 1211, whole aggregate was taken up at a ratc similar to that seen with THP-1 cells and was also resistant to stripping in acid buffer. In contrast, mouse macrophages took up less than 0.2% of the PG fragments over a period o f 5 min.
These very different rates of uptake, the different sensitivities to temperature and PMSF, and the different affinities shown by macrophages and THP-1 cells, suggest that the mechanism of recognition and uptake of the proteolytic fragments is different from that of whole PG aggregate. Experiments are in progress to determine whether these acid-strippable PG fragments are associated with class II antigens on the THP-1 cell membrane.
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